• GLB1 gene;
  • GM1 gangliosidosis;
  • mutation analysis;
  • phenotype-genotype correlation

GM1 gangliosidosis manifests with progressive psychomotor deterioration and dysostosis of infantile, juvenile, or adult onset, caused by alterations in the structural gene coding for lysosomal acid β-galactosidase (GLB1). In addition allelic variants of this gene can result in Morquio B disease, a phenotype with dysostosis multiplex and entire lack of neurologic involvement. More than 100 sequence alterations in the GLB1 gene have been identified so far, but only few could be proven to be predictive for one of the GM1 gangliosidosis subtypes or Morquio B disease. We performed genotype analyses in sixteen GM1 gangliosidosis patients of all phenotypes and detected twenty-eight different genetic lesions. Among these, p.I55FfsX16, p.W65X, p.F107L, p.H112P, p.C127Y, p.W161X, p.I181K, p.C230R, p.W273X, p.R299VfsX5, p.A301V, p.F357L, p.K359KfsX23, p.L389P, p.D448V, p.D448GfsX8, and the intronic mutation IVS6-8A>G have not been published so far. Due to their occurrence in homozygous patients, four mutations could be correlated to a distinct GM1 gangliosidosis phenotype. Furthermore, the missense mutations from heteroallelic patients and three artificial nonsense mutations were characterized by overexpression in COS-1 cells and the subcellular localization of the mutant proteins in fibroblasts was assessed. The phenotype specificity of ten alleles can be proposed on the basis of our results and previous data.